224 related articles for article (PubMed ID: 24450530)
1. Purple toes syndrome following stroke thrombolysis and warfarin therapy.
Mooney T; Joseph P
Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530
[No Abstract] [Full Text] [Related]
2. Fatal multiple systemic emboli after intravenous thrombolysis for cardioembolic stroke.
Tanaka K; Ohara T; Ishigami A; Ikeda Y; Matsushige T; Satow T; Ishibashi-Ueda H; Iihara K; Toyoda K
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):395-7. PubMed ID: 23545321
[TBL] [Abstract][Full Text] [Related]
3. The purple toe syndrome in female with Factor V Leiden mutation successfully treated with enoxaparin.
Dulíček P; Bártová J; Beránek M; Malý J; Pecka M
Clin Appl Thromb Hemost; 2013; 19(1):100-2. PubMed ID: 22531482
[TBL] [Abstract][Full Text] [Related]
4. [Postoperative ischemic acute stroke and thrombolytic therapy].
Laalou FZ; Kuntzmann H; Mahoudeau G; Kremer S; Pain L
Ann Fr Anesth Reanim; 2009 Apr; 28(4):388-91. PubMed ID: 19329273
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
6. Very late IV thrombolysis in acute ischemic stroke: a successful case in proximal MCA occlusion.
Joux J; Nazarov B; Olindo S; Smadja D
Clin Neurol Neurosurg; 2012 Jul; 114(6):820-2. PubMed ID: 22341929
[No Abstract] [Full Text] [Related]
7. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy for acute stroke in a teenager.
Muñiz AE
Pediatr Emerg Care; 2012 Feb; 28(2):170-3. PubMed ID: 22307187
[TBL] [Abstract][Full Text] [Related]
9. [Future developments in thrombolytic therapy].
Bode C; Runge MS
Z Kardiol; 1993; 82 Suppl 2():187-90. PubMed ID: 8328201
[TBL] [Abstract][Full Text] [Related]
10. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
[TBL] [Abstract][Full Text] [Related]
11. Thrombolytic-associated coagulopathy and management dilemmas: a review of two cases.
Illoh OC; Illoh K
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):605-7. PubMed ID: 18685447
[TBL] [Abstract][Full Text] [Related]
12. A Myocardial Infarction During Intravenous Recombinant Tissue Plasminogen Activator Infusion for Evolving Ischemic Stroke.
Fitzek S; Fitzek C
Neurologist; 2015 Sep; 20(3):46-7. PubMed ID: 26375375
[TBL] [Abstract][Full Text] [Related]
13. Thrombolysis for stroke in the over 80s.
Ford GA
Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
[No Abstract] [Full Text] [Related]
14. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator.
Wang CT; Lin FC; Khor GT; Chen CH; Huang P
Am J Emerg Med; 2012 Jan; 30(1):253.e1-2. PubMed ID: 21109385
[TBL] [Abstract][Full Text] [Related]
16. [Orolingual angiooedema following intravenous thrombolysis].
Arias-Rivas S; Pardo M; Rodriguez-Yanez M; Lopez-Ferreiro A; Blanco M
Rev Neurol; 2013 Jul; 57(1):46-7. PubMed ID: 23799603
[TBL] [Abstract][Full Text] [Related]
17. Thrombolysis for stroke.
Fitzgerald M; Gerraty RP
Med J Aust; 2010 Oct; 193(8):436-7. PubMed ID: 20955117
[No Abstract] [Full Text] [Related]
18. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
Ben-Chitrit S; Korzets Z; Hershkovitz R; Bernheim J; Schneider M; Bernheim J
Nephrol Dial Transplant; 1994; 9(4):428-30. PubMed ID: 8084460
[No Abstract] [Full Text] [Related]
19. Correlative magnetic resonance imaging and autopsy findings in a patient with coagulation necrosis treated with tissue plasminogen activator.
Suzuki M; Uchihara T; Toru S; Bae Y; Igari T; Kitagawa M; Uchiyama S; Hirokawa K; Kobayashi T
J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):512-4. PubMed ID: 22000524
[TBL] [Abstract][Full Text] [Related]
20. Right internal carotid artery occlusion during intravenous thrombolysis for left middle cerebral artery occlusion.
Yalcin-Cakmakli G; Akpinar E; Topcuoglu MA; Dalkara T
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):74-7. PubMed ID: 19110150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
